According to Citi analysts, Amgen’s acquisition of Dark Blue could further drive the strength of Amgen’s early oncology ...

Cellenkos has received orphan drug designation from the US FDA for its investigational CK0804 Treg therapy to treat ...

Nimbus will apply its computational chemistry and structure-based drug design to a discovery programme in obesity treatment.

Zai Lab has received approval from China’s NMPA for the sNDA for Augtyro to treat adult patients with solid tumours ...

Ypsomed will establish its first manufacturing facility in the US. The company has selected Holly Springs in Wake County, North Carolina, as the location, and will invest around CHF200m in a first ...